COMPARISON OF OUTCOME OF PATIENTS WITH UNSTABLE ANGINA AND NON-Q-WAVEACUTE MYOCARDIAL-INFARCTION WITH AND WITHOUT PRIOR CORONARY-ARTERY BYPASS-GRAFTING (THROMBOLYSIS IN MYOCARDIAL-ISCHEMIA-III REGISTRY)
Ns. Kleiman et al., COMPARISON OF OUTCOME OF PATIENTS WITH UNSTABLE ANGINA AND NON-Q-WAVEACUTE MYOCARDIAL-INFARCTION WITH AND WITHOUT PRIOR CORONARY-ARTERY BYPASS-GRAFTING (THROMBOLYSIS IN MYOCARDIAL-ISCHEMIA-III REGISTRY), The American journal of cardiology, 77(4), 1996, pp. 227-231
The aim of this study was to characterize patients with and without pr
ior coronary artery bypass grafting (CABG) among a prospectively ident
ified cohort of patients presenting with unstable angina or non-Q-wave
myocardial infarction. Patients in the Thrombolysis in Myocardial Inf
arction phase III Registry Prospective Study presented within 96 hours
of an episode of unstable angina or non-Q-wave acute myocardial, infa
rction. Of 2,048 patients, 336 (16.4%) had prior CABG Compared with th
ose without prior CABG, patients were the same age, but were more like
ly to be men, white, diabetic, have a history of angina or myocardial
infarction, to have received anti-ischemic medications in the prior we
ek, and to receive intravenous heparin or nitroglycerin, or bath, duri
ng hospitalization. They were equally likely to undergo coronary angio
plasty or CABG. Death or nonfatal myocardial infarction occurred by da
y 10 in 4.5% of patients with prior CABG and 2.8% of patients without
prior CABG (p = 0.11); and by day 42 in 7.7% and 5.1%, respectively (p
= 0.03). The composite of death, myocardial infarction, or recurrent
ischemia at 1 year was more common among patients with prior CABG (39.
3% vs 30.2%, p = 0.002). By multiple logistic regression, prior CABG w
as not independently associated with the occurrence of death or myocar
dial infarction, or the composite of death, myocardial infarction, or
recurrent ischemia either at 6 weeks or at 1 year. The likelihood of r
ecurrent ischemic events is greater among patients with than without p
rior CASG, but is most likely explained by differences in baseline or
treatment characteristics which reflect the degree of underlying cardi
ac disease.